Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory...

cannot be taken in tablet form. These are anakinra, canakinumab and rilonacept. Rilonacept has been specifically approved as an orphan drug for use in this...

Canakinumab is another anti-IL1 drug which selectively binds IL-1β and rilonacept which blocks both IL-1A and IL-1β. The monoclonal anti-IL6 antibody tocilizumab...

Yancopoulos in 1988. Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker. VEGF is a protein that normally stimulates...

and anti-interleukin-1 medications, such as anakinra, canakinumab, or rilonacept, are highly successful in managing the disease's systemic symptoms. Up...

many countries for treatment of cryopyrin-associated periodic syndromes. Rilonacept is an IL-1 trap developed by Regeneron targeting IL-1B, and approved in...

become a common therapeutic target, and medications such as anakinra, rilonacept, and canakinumab have revolutionized the treatment of autoinflammatory...

Opinercept L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab...

Antibodies -cept (Fusion) CTLA-4 Abatacept Belatacept TNF inhibitor Etanercept Opinercept Aflibercept Alefacept Rilonacept...

23 February 2023. Wan Y (29 October 2009). "Canakinumab (Ilaris) and rilonacept (Arcalyst) approved in EU for treatment of cryopyrin-associated periodic...